These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33580439)

  • 1. Targeting Mitochondrial Dysfunction for Bipolar Disorder.
    Kuperberg M; Greenebaum SLA; Nierenberg AA
    Curr Top Behav Neurosci; 2021; 48():61-99. PubMed ID: 33580439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.
    Madireddy S; Madireddy S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder.
    Scaini G; Andrews T; Lima CNC; Benevenuto D; Streck EL; Quevedo J
    Mitochondrion; 2021 Mar; 57():23-36. PubMed ID: 33340709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder.
    Chang CC; Jou SH; Lin TT; Liu CS
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):551-7. PubMed ID: 24447331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.
    Valvassori SS; Bavaresco DV; Feier G; Cechinel-Recco K; Steckert AV; Varela RB; Borges C; Carvalho-Silva M; Gomes LM; Streck EL; Quevedo J
    Psychiatry Res; 2018 Jun; 264():192-201. PubMed ID: 29653348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.
    Nierenberg AA; Kansky C; Brennan BP; Shelton RC; Perlis R; Iosifescu DV
    Aust N Z J Psychiatry; 2013 Jan; 47(1):26-42. PubMed ID: 22711881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.
    Scaini G; Rezin GT; Carvalho AF; Streck EL; Berk M; Quevedo J
    Neurosci Biobehav Rev; 2016 Sep; 68():694-713. PubMed ID: 27377693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria dysfunction and bipolar disorder: From pathology to therapy.
    Lam XJ; Xu B; Yeo PL; Cheah PS; Ling KH
    IBRO Neurosci Rep; 2023 Jun; 14():407-418. PubMed ID: 37388495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.
    Iwamoto K; Bundo M; Kato T
    Hum Mol Genet; 2005 Jan; 14(2):241-53. PubMed ID: 15563509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Agents for Bipolar Disorder.
    Pereira C; Chavarria V; Vian J; Ashton MM; Berk M; Marx W; Dean OM
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):550-569. PubMed ID: 29596661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.
    Callaly E; Walder K; Morris G; Maes M; Debnath M; Berk M
    Mini Rev Med Chem; 2015; 15(5):355-65. PubMed ID: 25807948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological hypotheses and biomarkers of bipolar disorder.
    Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder.
    Cordeiro RC; Lima CNC; Fries GR; Zunta-Soares G; Soares JC; Quevedo J; Scaini G
    Mol Psychiatry; 2023 Nov; 28(11):4622-4631. PubMed ID: 37723283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral biomarkers of mitochondrial dysfunction in adolescents with bipolar disorder.
    Jeong H; Dimick MK; Sultan A; Duong A; Park SS; El Soufi El Sabbagh D; Goldstein BI; Andreazza AC
    J Psychiatr Res; 2020 Apr; 123():187-193. PubMed ID: 32078836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular models to study bipolar disorder: A systematic review.
    Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S
    J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment.
    Andreazza AC; Young LT
    Int J Neuropsychopharmacol; 2014 Jul; 17(7):1039-52. PubMed ID: 23449044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyruvate dehydrogenase complex disorder hypothesis for bipolar disorder.
    Campbell I; Campbell H
    Med Hypotheses; 2019 Sep; 130():109263. PubMed ID: 31383331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond.
    Kato T
    Schizophr Res; 2017 Sep; 187():62-66. PubMed ID: 27839913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.